Establishment of the 1st Chinese national standard for CA6 neutralizing antibody
Coxsackievirus A6 (CA6) is one of the major causative agents of herpangina and hand-foot-mouth disease (HFMD). Since 2008, CA6 has circulated widely around the world. Especially in Asia-Pacific region CA6 had even replaced enterovirus A71 (EV71) and coxsackievirus A16 (CA16) as the main prevalent st...
Main Authors: | Yiping Wang, Fan Gao, Zhenglun Liang, Huimin Sun, Junzhi Wang, Qunying Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-01-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2022.2164140 |
Similar Items
-
Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo
by: Xin Yao, et al.
Published: (2018-05-01) -
A screening study on the detection strain of Coxsackievirus A6: the key to evaluating neutralizing antibodies in vaccines
by: Fan Gao, et al.
Published: (2024-12-01) -
A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge
by: Ruixiao Du, et al.
Published: (2019-10-01) -
Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains
by: Yaqian Huo, et al.
Published: (2021-12-01) -
Neutralizing Antibodies against Enteroviruses in Patients with Hand, Foot and Mouth Disease
by: Lam Anh Nguyet, et al.
Published: (2020-02-01)